Related Experiment Video

Updated: Jun 17, 2026

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
19:16

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

[Cystatin C: a protein for heart failure]

Juan Ignacio Pérez-Calvo1, José Luis Morales Rull, Francisco José Ruiz Ruiz

  • 1Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. jiperez@unizar.es

Medicina Clinica
|January 2, 2010
PubMed

Insights

Cystatin C (CysC), an antiprotease, is a valuable biomarker for kidney function and offers significant prognostic insights in cardiovascular diseases. Research explores its potential as an early indicator of ventricular remodeling.

Area of Science:

  • Biochemistry
  • Cardiology
  • Nephrology

Context:

  • Cystatin C (CysC) is recognized for its role as an antiprotease and its utility in assessing kidney function.
  • Emerging evidence highlights CysC's prognostic significance across various cardiovascular conditions.

Purpose:

  • To review existing data supporting Cystatin C (CysC) as a prognostic factor in cardiovascular diseases.
  • To explore the potential of CysC as an early marker for ventricular remodeling.

Summary:

  • This review consolidates evidence on Cystatin C (CysC) as a prognostic biomarker in cardiovascular diseases, including in healthy elderly, hypertensive, and heart failure populations.
  • The potential role of CysC as a local antiprotease in the pathogenesis of ventricular remodeling is discussed.

Impact:

  • Cystatin C (CysC) offers valuable prognostic information beyond kidney function assessment in cardiovascular disease.
  • Further research is needed to fully elucidate the role of CysC in the pathophysiology and clinical management of cardiovascular diseases.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...